Kodiak Sciences enrolls first patients in Phase 3 DME trial

August 10, 2026 4:44 PM

Kodiak Sciences Inc. (Nasdaq: KOD) announced that the first patients have been enrolled in its global Phase 3 ALTO trial ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found